Puppo, Margherita http://orcid.org/0000-0003-1409-9577
Valluru, Manoj Kumar
Croset, Martine
Ceresa, Davide
Iuliani, Michele
Khan, Ashrin
Wicinski, Julien
Charafe-Jauffret, Emmanuelle
Ginestier, Christophe
Pantano, Francesco
Ottewell, Penelope Dawn
Clézardin, Philippe http://orcid.org/0000-0003-0149-4463
Funding for this research was provided by:
Ligue Contre le Cancer (CD71, LabelCG)
Article History
Received: 28 September 2022
Revised: 1 June 2023
Accepted: 20 June 2023
First Online: 13 July 2023
Competing interests
: We declare that we have no potential financial conflict of interest related to this manuscript. None of the material in this work has been published or is under consideration for publication elsewhere.
: For BC patient serum samples, ethics approval was obtained for the AZURE trial at UK centres, in accordance with the Declaration of Helsinki principles [CitationRef removed]. Participants involved in the original AZURE trial gave additional consent for blood donation at study entry to be used for biomarker assessment. For peripheral blood mononuclear cells of healthy donors, the procedure was approved by the Ethical Committee of Campus Bio-Medico University of Rome (Prot. 21/15 OSS), in accordance with the Declaration of Helsinki principles.
: Not applicable.